Published 2 months ago

US judge upholds Medicare drug price negotiation program

A federal judge rejected AstraZeneca's challenge to Medicare's drug price negotiations, a win for the Biden admin.
AstraZeneca claimed huge discounts under the negotiations, but Connolly stated it was a voluntary economic opportunity.
Judge Connolly dismissed the lawsuit as AstraZeneca failed to identify a protected property at risk due to the talks.

Insights by Ground AI

Does this summary seem wrong?

0 Articles

All

Left

Center

Right

Reuters

US Judge Upholds Medicare Drug Price Negotiation Program

2 months ago·United Kingdom

Read Full Article

CNN

Judge upholds Medicare drug price negotiation program

Medicare’s historic drug price negotiation program has survived its first court challenge by a drugmaker.

2 months ago·Atlanta, United States

Read Full Article

KRDO

Judge upholds Medicare drug price negotiation program, but more lawsuits are being considered in other courts

By Tami Luhby, CNN (CNN) — Medicare’s historic drug price negotiation program has survived its first court challenge by a drugmaker. A federal district court judge in Delaware on Friday rejected AstraZeneca’s claims that the negotiation program was unconstitutional and deprived the pharmaceutical company of its protected property interest. AstraZeneca’s Farxiga drug, which treats chronic kidney disease, heart failure and Type 2 diabetes, was amo…

2 months ago·Colorado Springs, United States

Read Full Article

CNBC

Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations

U.S. District Judge Colm Connolly's decision comes one day before manufacturers have to respond to Medicare's initial price offers for their drugs.

2 months ago·United States

Read Full Article

The Epoch Times

Judge Dismisses AstraZeneca’s Challenge to Medicare Drug Price Negotiation

A federal judge in Delaware on Friday denied AstraZeneca’s lawsuit challenging the constitutionality of Medicare’s drug price negotiation program, citing the company’s lack of legal standing. In his March 1 ruling, U.S. District Judge Colm Connolly stated that the pharmaceutical company lacked standing to challenge the guidance issued by Medicare to implement the program. The judge also stated that AstraZeneca failed to identify any property int…

2 months ago·New York, United States

Read Full Article

New Hampshire Union Leader

Judge upholds Medicare drug price negotiation program

A federal judge in Delaware on Friday upheld a law that requires some drugmakers to negotiate prices with the U.S government's Medicare health insurance program, rejecting a challenge by AstraZeneca to one of Democratic President Joe Biden's signature initiatives.

2 months ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year